Product Categories and Disease Areas
Expertise across complex therapies and real-world care pathways.
We build solutions across the entire treatment ecosystem, from product to real-world care.
Our services are designed to manage regulatory and logistical complexity while staying focused on what matters most: patient safety, product integrity, and reliable execution in real-world healthcare settings.
Across today’s clinical and commercial landscapes, the diversity of product types and therapeutic areas continues to expand. From investigational medicines and advanced therapies to specialty drugs, diagnostics, and devices, each category presents its own regulatory, operational, and clinical challenges.
What sets Komtur apart is not just our ability to move products, but our understanding of the ecosystems they operate in. We combine product expertise with deep therapeutic knowledge, connecting manufacturers, hospitals, investigators, pharmacists, patient support structures, and authorities into a coherent and compliant access pathway.
This perspective enables more than delivery. It supports better planning, faster onboarding, earlier risk identification, and sustainable access across the full product lifecycle.
text text
Core Product Categories
Experience across high-value, high-complexity product types.
These categories reflect the therapies and technologies we routinely support across clinical development, hospital care, and post-approval access pathways.
Investigational Medicinal Products (IMP)
Investigational Medicinal Products (IMP)
Medicinal products or biologics under investigation in clinical trials to assess safety, efficacy, and optimal dosing. This includes investigational treatments, comparators, and placebos used to generate robust clinical evidence prior to approval.
Investigational Medicinal Products (IMP)
Komtur Service: QP release, blinding, compliant labeling, supply coordination, and reliable site delivery are managed end to end in alignment with study protocols and country-specific regulatory requirements.
Cell and Gene Therapy (ATMPs)
Cell and Gene Therapy (ATMPs)
Advanced therapies based on genes, cells, or engineered tissues, including gene therapies, cell therapies, and tissue-engineered products. These therapies operate under specialised regulatory frameworks due to their complexity and transformative potential.
Cell and Gene Therapy (ATMPs)
Komtur Service: ATMPs requiring chain-of-identity, cold chain control, and site readiness are supported through tightly controlled processes to ensure product integrity, regulatory compliance, and reliable administration at clinical sites.
Nutraceuticals
Nutraceuticals
Products derived from food sources that provide health or wellness benefits beyond basic nutrition, including supplements and functional ingredients.
Nutraceuticals
Komtur Service: Licensed distribution in selected markets is supported and, where permitted under local regulation, nutraceuticals are integrated into trial protocols, patient care, and supportive therapy pathways.
Diagnostic Medical Devices
Diagnostic Medical Devices
Devices and tests used to identify, stratify, or monitor patients before or during treatment, including companion diagnostics linked to specific therapies.
Diagnostic Medical Devices
Komtur Service: Diagnostic devices are integrated into clinical workflows to support accurate data collection, operational efficiency, and compliant trial and care execution.
Controlled Substances
Controlled Substances
Medicinal products subject to special legal controls due to risks of abuse, dependence, or diversion, requiring strict handling and documentation throughout their lifecycle.
Controlled Substances
Komtur Service: Controlled medicines are managed through secure storage, controlled transport, and structured authority interfaces to ensure regulatory compliance and risk mitigation.
Ancillary Medication
Ancillary Medication
Medicines administered alongside investigational treatments to support patient safety, manage side effects, or meet protocol requirements.
Ancillary Medication
Komtur Service: Ancillary and supportive therapies are aligned with study protocols and site-specific clinical practice to ensure safe and compliant trial execution.
Placebo
Placebo
Inactive products designed to match the investigational or comparator treatment in appearance and administration, supporting unbiased trial design and data integrity.
Placebo
Komtur Service: Matched presentation for blinded trial designs is ensured, with documentation and controls in place to support regulatory compliance and trial integrity.
Therapeutic Medical Devices
Therapeutic Medical Devices
Medical devices delivering treatment through mechanical, physical, or digital means, used in both clinical and post-approval care settings.
Therapeutic Medical Devices
Komtur Service: Treatment-enabling devices are supported through site enablement, training coordination, access planning, and compliant distribution to ensure safe and effective use in clinical practice and patient support programs.
Veterinary Drugs
Veterinary Drugs
Medicinal products developed for the prevention, diagnosis, or treatment of diseases in animals, regulated separately from human medicines.
Veterinary Drugs
Komtur Service: Where relevant and permitted, compliant supply and execution support are provided to veterinary centres.
Comparators
Comparators
Approved medicinal products used as reference treatments in clinical trials to benchmark safety and efficacy against investigational therapies.
Comparators
Komtur Service: Reference medicines and co-medications are sourced with full documentation to ensure traceability, regulatory compliance, and seamless integration into clinical study supply chains.
Commercial and Post-Approval Product Categories
These categories reflect products primarily supplied in approved, post-authorization, or market-access contexts, including early access, named patient programs, and ongoing commercial distribution.
Biosimilars
Biosimilars
Biologic medicines highly similar to approved reference biologics, with no clinically meaningful differences in safety, purity, or potency.
Biosimilars
Komtur Service: Biosimilars are supported through structured access pathways and regulatory documentation to enable compliant adoption and effective clinical use.
Generics
Generics
Medicinal products containing the same active substance as reference products and demonstrating bioequivalence following patent expiry.
Generics
Komtur Service: Approved multisource equivalents are supported for clinical trials, access pathways, and shortage recovery to maintain continuity of treatment.
Branded Drugs
Branded Drugs
Originator medicinal products approved for clinical use and protected by intellectual property rights.
Branded Drugs
Komtur Service: Licensed distribution and post-launch support are provided across approved markets to enable patient access, continuity of care, and compliant supply.
Orphan and Ultra-Orphan Drugs
Orphan and Ultra-Orphan Drugs
Medicinal products developed for rare diseases affecting small patient populations, often supported by specific regulatory incentives.
Orphan and Ultra-Orphan Drugs
Komtur Service: Rare-disease therapies are supported through eligibility management, authority engagement, and continuity planning to ensure compliant and uninterrupted patient access.
Disease Areas
Real-world expertise across high-impact and hard-to-reach therapy areas.
These areas reflect where we support partners with sourcing, access, and distribution strategies that work beyond theory.
Many of these therapy areas overlap in practice. Our services are designed to operate across disease boundaries where products, patients, and care pathways intersect.
- Cardiology and Metabolic Diseases
- Dermatology
- Endocrinology and Rare Metabolic Diseases
- Gastroenterology and Hepatology
- General Medicine and Emergency Care
- Hematology
- Immunology and Autoimmune Diseases
- Infectious Disease
- Neurology
- Ophthalmology
- Oncology
- Otolaryngology and Balance Disorders
- Psychiatry and Behavioral Disorders
- Pulmonology (Respiratory)
- Reproductive Medicine and Gynecology
- Rheumatology and Orthopedics
- Urology and Nephrology
Beyond the Product
Supporting the broader realities of patient care and product quality.
Therapy does not exist in isolation. Our services extend beyond the product itself to help patients stay on treatment and ensure quality standards are upheld throughout the lifecycle.
Quality of Life and Social Circumstances
Quality of Life and Social Circumstances
Patient support beyond the product, addressing adherence, education, and practical barriers to care.
Quality of Life and Social Circumstances
Komtur Service: Patient-centric access models and supportive care coordination reduce barriers and sustain continuity of treatment.
Product-Related Issues
Product-Related Issues
Management of quality events including deviations, complaints, recalls, and compliant product returns or destruction.
Product-Related Issues
Komtur Service: Structured quality processes and regulatory coordination ensure patient safety, compliance, and supply continuity across the product lifecycle.
Explore Further
Compliance Note
All services described are subject to applicable local laws, licensing requirements, and regulatory approvals. Availability and scope may vary by country and product status. Komtur does not provide medical advice, prescribe therapies, or replace clinical decision-making by healthcare professionals.